Loading…

Sustained exercise hyperemia during prolonged adenosine infusion in humans

The contribution of Adenosine (ADO) to exercise hyperemia remains controversial and it is unknown whether ADO can evoke the prolonged vasodilation seen during exercise bouts. Therefore, we tested hypotheses in the human forearm during 3 h of intra‐arterial high dose ADO infusion: (1) skeletal muscle...

Full description

Bibliographic Details
Main Authors: Ranadive, Sushant M., Shepherd, John R. A., Curry, Timothy B., Dinenno, Frank A., Joyner, Michael J.
Format: Online Article Text
Language:English
Published: John Wiley and Sons Inc. 2019
Subjects:
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389741/
https://www.ncbi.nlm.nih.gov/pubmed/30806018
http://dx.doi.org/10.14814/phy2.14009
_version_ 1783397993174532096
author Ranadive, Sushant M.
Shepherd, John R. A.
Curry, Timothy B.
Dinenno, Frank A.
Joyner, Michael J.
author_facet Ranadive, Sushant M.
Shepherd, John R. A.
Curry, Timothy B.
Dinenno, Frank A.
Joyner, Michael J.
author_sort Ranadive, Sushant M.
collection PubMed
description The contribution of Adenosine (ADO) to exercise hyperemia remains controversial and it is unknown whether ADO can evoke the prolonged vasodilation seen during exercise bouts. Therefore, we tested hypotheses in the human forearm during 3 h of intra‐arterial high dose ADO infusion: (1) skeletal muscle blood flow would wane over time; (2) exercise hyperemic responses during ADO administration would be unaffected compared to baseline. Using sodium nitroprusside (SNP), we tested parallel hypotheses regarding nitric oxide (NO) in a separate group of participants. Seventeen young healthy participants (ADO: n = 9; SNP: n = 8) performed multiple rhythmic handgrip exercise bouts (20% of maximum), two during saline and five during 3 h of continuous drug infusion. Five minutes of ADO infusion resulted in a ~5‐fold increase in forearm vascular conductance (FVC; 4.8 ± 0.6 vs. 24.2 ± 3.2 mL/min/100 mmHg, P < 0.05). SNP caused a ~4‐fold increase (4.4 ± 0.6 vs. 16.6 ± 2 mL/min/100 mmHg, P < 0.05). FVC did not wane over time with ADO (24.2 ± 3.2 and 22 ± 1.2 mL/min/100 mmHg [P > 0.05]) or SNP (16.6 ± 2 and 14.1 ± 2.4 mL/min(/)100 mmHg [P > 0.05]) at 5 versus 150 min. Superimposed exercise during ADO or SNP infusions evoked marked and consistent additional dilation over the course of the infusions. Our findings demonstrate that in humans there is no reduction in endothelial or vascular smooth muscle responsiveness to the exogenous vasodilatory metabolites ADO and NO. Additionally, even in the presence of an exogenous vasodilator, superimposed exercise can cause significant hyperemia.
format Online
Article
Text
id pubmed-6389741
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63897412019-03-07 Sustained exercise hyperemia during prolonged adenosine infusion in humans Ranadive, Sushant M. Shepherd, John R. A. Curry, Timothy B. Dinenno, Frank A. Joyner, Michael J. Physiol Rep Original Research The contribution of Adenosine (ADO) to exercise hyperemia remains controversial and it is unknown whether ADO can evoke the prolonged vasodilation seen during exercise bouts. Therefore, we tested hypotheses in the human forearm during 3 h of intra‐arterial high dose ADO infusion: (1) skeletal muscle blood flow would wane over time; (2) exercise hyperemic responses during ADO administration would be unaffected compared to baseline. Using sodium nitroprusside (SNP), we tested parallel hypotheses regarding nitric oxide (NO) in a separate group of participants. Seventeen young healthy participants (ADO: n = 9; SNP: n = 8) performed multiple rhythmic handgrip exercise bouts (20% of maximum), two during saline and five during 3 h of continuous drug infusion. Five minutes of ADO infusion resulted in a ~5‐fold increase in forearm vascular conductance (FVC; 4.8 ± 0.6 vs. 24.2 ± 3.2 mL/min/100 mmHg, P < 0.05). SNP caused a ~4‐fold increase (4.4 ± 0.6 vs. 16.6 ± 2 mL/min/100 mmHg, P < 0.05). FVC did not wane over time with ADO (24.2 ± 3.2 and 22 ± 1.2 mL/min/100 mmHg [P > 0.05]) or SNP (16.6 ± 2 and 14.1 ± 2.4 mL/min(/)100 mmHg [P > 0.05]) at 5 versus 150 min. Superimposed exercise during ADO or SNP infusions evoked marked and consistent additional dilation over the course of the infusions. Our findings demonstrate that in humans there is no reduction in endothelial or vascular smooth muscle responsiveness to the exogenous vasodilatory metabolites ADO and NO. Additionally, even in the presence of an exogenous vasodilator, superimposed exercise can cause significant hyperemia. John Wiley and Sons Inc. 2019-02-25 /pmc/articles/PMC6389741/ /pubmed/30806018 http://dx.doi.org/10.14814/phy2.14009 Text en © 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Ranadive, Sushant M.
Shepherd, John R. A.
Curry, Timothy B.
Dinenno, Frank A.
Joyner, Michael J.
Sustained exercise hyperemia during prolonged adenosine infusion in humans
title Sustained exercise hyperemia during prolonged adenosine infusion in humans
title_full Sustained exercise hyperemia during prolonged adenosine infusion in humans
title_fullStr Sustained exercise hyperemia during prolonged adenosine infusion in humans
title_full_unstemmed Sustained exercise hyperemia during prolonged adenosine infusion in humans
title_short Sustained exercise hyperemia during prolonged adenosine infusion in humans
title_sort sustained exercise hyperemia during prolonged adenosine infusion in humans
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389741/
https://www.ncbi.nlm.nih.gov/pubmed/30806018
http://dx.doi.org/10.14814/phy2.14009
work_keys_str_mv AT ranadivesushantm sustainedexercisehyperemiaduringprolongedadenosineinfusioninhumans
AT shepherdjohnra sustainedexercisehyperemiaduringprolongedadenosineinfusioninhumans
AT currytimothyb sustainedexercisehyperemiaduringprolongedadenosineinfusioninhumans
AT dinennofranka sustainedexercisehyperemiaduringprolongedadenosineinfusioninhumans
AT joynermichaelj sustainedexercisehyperemiaduringprolongedadenosineinfusioninhumans